Study of the daily oral calcium effect on serum B12 level among patients Diabetes with type II metformin consumer

Not Applicable

Recruiting

• Conditions: Diabetic.; Diabetic nephropathy; N08.3*

• Registration Number: IRCT2017081925732N26
• Lead Sponsor: Qom University of Medical Sciences, Deputy of Research and Technology.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

people with type II diabetes mellitus are treated to metformin in aged 30 to 60 years; People with type II diabetes mellitus are treated to metformin for the last 2 years; diabetics are treated with 1 to 2 gram metformin.
Exclusion criteria: Current intake of calcium or B12 vitamin supplements; people with malabsorption, renal failure, kidney stone, liver disease, lung disease, anemia, gastrointestinal surgery, cancer, antibiotic use in the last two weeks; people with B12 vitamin deficiency

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Vitamin B12 serum. Timepoint: Before and after intervention. Method of measurement: blood test.;Calcium. Timepoint: Before and after intervention. Method of measurement: Exam.